期刊文献+

遗忘型轻度认知损害的早期诊断途径:从分子、影像到行为神经病学 被引量:4

下载PDF
导出
摘要 随着全球人口老龄化进程的加快,老年性痴呆及其相关问题已成为较为突出的社会公共卫生问题,而阿尔茨海默病(AD)作为老年性痴呆中最常见的类型,其基础与临床研究一直是神经病学的热点问题。尽管目前对阿尔茨海默病的病因学、病理学及生化学等研究均已取得了较为显著的成果,但在临床治疗方面仍缺乏有效的干预方法,有限的药物治疗和干预方法大多仅适用于早期阿尔茨海默病患者。
作者 程怀东 汪凯
出处 《中国现代神经疾病杂志》 CAS 2010年第2期155-159,共5页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 "十一五"国家科技支撑计划项日(项目编号:2006BAI02B01) 国家重点基础研究发展计划("973"计划)项目子课题(项目编号:2005CB522800) 国家自然科学基金资助项目(项目编号:30670706) 国家自然科学基金资助项目(项目编号:30870766)
  • 引文网络
  • 相关文献

参考文献47

  • 1Petersen RC.Mild cognitive impairment as a diagnostic entity.J Intern Med,2004,256:183-194.
  • 2Ganguli M,Dodge HH,Shen C,et al.Mild cognitive impairment,amnestic type:an epidemiologic study.Neurology,2004,63:115-121.
  • 3Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive impairment.Arch Neurol,2001,58:1985-1992.
  • 4Boyle PA,Wilson RS,Aggarwal NT,et al.Mild cognitive impairment:risk of Alzheimer disease and rate of cognitive decline.Neurology,2006,67:441-445.
  • 5Song F,Poljak A,Smythe GA,et al.Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.Brain Res Rev,2009,61:69-80.
  • 6Pomara N,Willoughby LM,Sidtis JJ,et al.Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up:a preliminary report.Am J Geriatr Psychiatry,2005,13:914-917.
  • 7Blennow K,Hampel H.CSF markers for incipient Alzheimer's disease.Lancet Neurol,2003,2:605-613.
  • 8Andreasen N,Minthon L,Davidsson P,et al.Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.Arch Neurol,2001,58:373-379.
  • 9Riemenschneider M,Lautenschlager N,Wagenpfeil S,et al.Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.Arch Neurol,2002,59:1729-1734.
  • 10Blasko I,Jellinger K,Kemmler G,et al.Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease:prediction by plasma amyloid beta 42,medial temporal lobe atrophy and homocysteine.Neurobiol Aging,2008,29:1-11.

二级参考文献32

  • 1Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurology, 2001, 58 : 1985-1992.
  • 2Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med, 2004, 256: 183-194.
  • 3Dudas RB, Clague F, Thompson SA, et al. Episodic and semantic memory in mild cognitive impairment. Neuropsychologia, 2005, 43 : 1266-1276.
  • 4Funahashi S. Neuronal mechanisms of executive control by the prefrontal cortex. Neurosci Res, 2001, 39 : 147-165.
  • 5Smith EE, Jonides J. Storage and executive processes in the frontal lobes. Science, 1999, 283: 1657-1661.
  • 6Hunt A, Schonknecht P, Henze M, et al. Neural correlates of executive function in Alzheimer' s disease and mild cognitive impairment. Clin Neurophysiol, 2007, 118 : e9-e116.
  • 7Baddeley A. Working memory. Science, 1992, 255 : 556-559.
  • 8Wilson FA, Scalaidhe SP, Goldman-Rakic PS. Dissociation of object and spatial processing domains in primate prefrontal cortex. Science, 1993, 260: 1955-1958.
  • 9Courtney SM, Ungerleider LG, Keil K, et al. Object and spatial visual working memory activate separate neural systems in human cortex. Cereb Cortex, 1996, 61 : 39-49.
  • 10Ventre-Dominey J, Bailly A, Lavenne F, et al. Double dissociation in neural correlates of visual working memory: a PET study. Brain Res Cogn Brain Res, 2005, 25 : 747-759.

共引文献20

同被引文献132

  • 1丁新生.阿尔茨海默病的生物学标志和影像学检查[J].中国现代神经疾病杂志,2005,5(3):141-146. 被引量:5
  • 2王涛,肖世富.阿尔茨海默病磁共振成像研究进展[J].中国现代神经疾病杂志,2007,7(1):76-79. 被引量:2
  • 3Loos C, Achten E, Santens P. Proton magnetic resonance spectroscopy in AlzheimerJs disease: a review. Acta Neurol Belg, 2010, 110:291-298.
  • 4Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry, 2005, 162: 667-675.
  • 5Shinno H, Inagaki T, Miyaoka T, et al. A decrease in N- acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease. J Neurol Sci, 2007, 260(1/2): 132-138.
  • 6Kantarci K, Petersen RC, Przybelski SA, et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol, 2008, 65:1621-1628.
  • 7Watanabe T, Shiino A, Akiguchi I. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord. 2010. 30:71-77.
  • 8Narayana PA, Johnston D, Flamig DP. In vivo proton magnetic resonance spectroscopy studies of human brain. Magn Reson Imaging, 1991, 9:303-308.
  • 9Lie DC, Song H, Colamarino SA, et al. Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharwacol Toxicol, 2004, 44:399-421.
  • 10Chen Q, Nakajima A, Choi SH, et al. Adult neurogenesis is functionally associated with AD - like neurodegeneration. Neurobiol Dis, 2008, 29:316-326.

引证文献4

二级引证文献17

;
使用帮助 返回顶部